Manufacturing Today Issue 205 Issue 205 - October 2022 | Page 131

Resilience is
set to continue enhancing its capabilities further progress .

apply them to our manufacturing and supply chains , then we can ’ t expect to be any less vulnerable to disruption , or death in the future . Integral to Resilience , is the belief that capital investment , however high , is needed in preparation both for the incredible potential of biomedical science , and the potential threats we ’ re likely to face .”

Moving forward , Resilience is set to continue enhancing its capabilities , bringing further

investments in process development and research innovation . “ Our aim is that in the next six months , we ’ ll be able to attain a number of customers , having realized our goal of becoming a one-stop-shop to serve the needs of biological innovators ,” Rahul confirms . “ Longer term , our mission in this company is to ultimately increase access and affordability to medicines and vaccines . Thanks to our excellence in biomanufacturing , we believe this is achievable , and we ’ re already on that path . Every day we ’ re making

Resilience is

set to continue enhancing its capabilities further progress .

“ Our hope is that within several years , we ’ ll have reshaped the world of biomanufacturing ,” he concludes . “ We want companies to be able to come to us with a drug , which we ’ re then able to scale up on their behalf . That way , it ’ ll enable them to focus on what they do best : delivering yet more biological innovations , and bringing benefits to an ever-growing number of patients .” ■
www . resilience . com
Resilience manufacturing-today . com 129